Narrative often shapes a person’s approach to healthcare decisions, yet narrative is usually excluded from the medical evidence base, and it rarely plays a role in original research reports.
People use stories and narrative to think, communicate, and make decisions about important facets of their lives, including healthcare. Narrative—the accounts of real-life events, either spoken or written from the viewpoint of someone who has experienced them—often shapes a person's approach to healthcare decisions, yet narrative is usually excluded from the medical evidence base, and it rarely plays a role in original research reports.
Stories and judgments, as well as other forms of narrative, remain poorly understood, said Daniel Dohan, PhD, of the Philip R. Lee Institute for Health Policy Studies at the University of California San Francisco, and colleagues, who studied the role of narrative in patients’ healthcare decision making in their analysis in the April 2016 issue of Health Affairs.
The authors envision a future in which it will be important to integrate narrative data into health science research and healthcare decision making. Developing new qualitative research tools could help ensure that patients, clinicians, researchers, and policy makers account for and benefit from the power of stories in health decision making.
In healthcare decision making, narrative can trump the evidence base for several reasons, according to the authors. Medical evidence may not measure patient-centered outcomes, may not include diverse populations, and may overlook issues related to chronic illnesses or comorbidities.
“Quantitative data can be confusing or seem irrelevant in the midst of decision making,” the authors wrote.
In contrast, accounts of illnesses and treatments, cautionary tales, previous experiences, and common sense, may seem more compelling.
“Such narratives may not constitute a reliable basis for sound healthcare decision making on their own, but handled appropriately they can be helpful to patients and clinicians,” according to the researchers.
Dr Dohan and his colleagues describe new tools and approaches that can be used to link narrative-based, qualitative research findings with quantitative health science scholarship so that narrative can be more fully integrated into the medical evidence base and evidence-based medical practice. Among their suggestions is the recommendation to embrace insights and perspectives gleaned from stories and narrative and examine what narrative means and how to distinguish data from anecdote.
The article cited a critical need to establish guidelines for qualitative research, but concedes that there have been many unsuccessful attempts to create such guidelines.
Furthermore, there are not yet ways to adequately shield the confidentiality of research subjects in large qualitative health studies, because aggregating data to preserve confidentiality destroys the richness that makes qualitative data valuable. Thus, innovative approaches are needed to allow for sharing of qualitative data on a large scale, something that is needed if narrative is to take its rightful place in the healthcare decision making process.
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
More Care Doesn't Equal Happier Patients in Traditional Medicare
March 17th 2025Data on care satisfaction, ease managing care, and out-of-pocket spending were the outcomes of interest for this new analysis that investigated the relationship between healthcare utilization and beneficiary experience within traditional Medicare.
Read More
Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year
March 17th 2025As St. Patrick's Day brings global celebrations involving alcohol, Ireland looks forward to rethinking excess consumption with a new tool set to arrive next year: the world's most comprehensive alcohol warning label.
Read More